BD, Franklin Lakes, NJ, has launched its next-generation wireless rapid diagnostic system for detection of group A Strep, influenza A and B, and respiratory syncytial virus (RSV), with new traceability and secure patient health record documentation features and functionality.
The wireless BD Veritor Plus system provides healthcare providers and laboratorians in physician offices, clinics, hospitals, and integrated delivery networks with objective, lab-quality immunoassay test results within minutes. The system is designed to streamline point-of-care (POC) diagnostic workflow and enables providers to quickly review patient results to assist in determining the appropriate treatment in a single consultation.
The system leverages the demonstrated performance of the legacy BD Veritor system and offers new features to improve quality control (QC) by identifying QC results. The enhanced documentation functionality includes user ID, specimen ID, and test kit lot to improve traceability, which decreases manual documentation.
The new system also offers the BD cloud connectivity solution?a technology that allows users to transfer test data wirelessly and securely to an electronic medical record or a laboratory information system to enable data access across an entire integrated delivery network. The new features seek to reduce potential errors associated with manual documentation and to enable physicians to access test results more easily in order to determine next steps in patient care.
“As we are on the cusp of the flu season, it is critical that providers have the diagnostic tools they need to assist them in quickly and accurately identifying infectious diseases, like flu, RSV, and Strep, and in assigning treatment protocols,” says Dave Hickey, president of diagnostic systems at BD. “The BD Veritor Plus system’s ability to provide reliable test results and wirelessly transfer them to health records could ultimately lead to better outcomes through rapid detection and simplified workflow.”
For more information, visit BD.